For: | Gu ZD, Chen KN, Li M, Gu J, Li JY. Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma. World J Gastroenterol 2005; 11(6): 871-874 [PMID: 15682484 DOI: 10.3748/wjg.v11.i6.871] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i6/871.htm |
Number | Citing Articles |
1 |
Nooshin Mohtasham, Shahab Babakoohi, Atena Shiva, Arash Shadman, Kambiz Kamyab-Hesari, Mohammad-Taghi Shakeri, Noorieh Sharifi-Sistani. Immunohistochemical study of p53, Ki-67, MMP-2 and MMP-9 expression at invasive front of squamous cell and verrucous carcinoma in oral cavity. Pathology - Research and Practice 2013; 209(2): 110 doi: 10.1016/j.prp.2012.11.002
|
2 |
Evaluation of matrix metalloproteinase-9 expressions in nasopharyngeal carcinoma patients. IOP Conference Series: Earth and Environmental Science 2018; 125: 012130 doi: 10.1088/1755-1315/125/1/012130
|
3 |
K. N. Syrigos, A. Zalonis, E. Kotteas, Muhammad Wasif Saif. Targeted therapy for oesophageal cancer: an overview. Cancer and Metastasis Reviews 2008; 27(2): 273 doi: 10.1007/s10555-008-9117-z
|
4 |
Makoto Sugimoto, Shigeki Yoshida, Stephen Kennedy, Masashi Deguchi, Nyriyuki Ohara, Takeshi Maruo. Matrix Metalloproteinase-1 and -9 Promoter Polymorphisms and Endometrial Carcinoma Risk in a Japanese Population. Journal of the Society for Gynecologic Investigation 2006; 13(7): 523 doi: 10.1016/j.jsgi.2006.07.001
|
5 |
H. Liu, Y.-R. Qin, J. Bi, A. Guo, L. Fu, X.-Y. Guan. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma. Diseases of the Esophagus 2012; 25(7): 656 doi: 10.1111/j.1442-2050.2011.01284.x
|
6 |
Kenneth K. Lai, Kin-Tak Chan, Sarwat Fatima, Nikki P. Lee, Simon Law. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine. 2013; : 85 doi: 10.1007/978-1-62703-456-2_6
|
7 |
Ziqi Ye, Hongying Zhao, Wuyuan Zhou, Tao Ye, Chong Geng, Xiaofeng Li, Lei Yuan, Mingyu Du, Heng Xu, Qiang Wang. <p>Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis</p>. OncoTargets and Therapy 2020; : 12857 doi: 10.2147/OTT.S280791
|
8 |
Hui Shi, Yuchen Wu, Yang Wang, Ming Zhou, Shu Yan, Zhimin Chen, Dawei Gu, Yunqing Cai. Liquiritigenin Potentiates the Inhibitory Effects of Cisplatin on Invasion and Metastasis Via Downregulation MMP-2/9 and PI3 K/AKT Signaling Pathway in B16F10 Melanoma Cells and Mice Model. Nutrition and Cancer 2015; 67(5): 761 doi: 10.1080/01635581.2015.1037962
|
9 |
Jong-Shiaw Jin, Chen-Wen Yao, Shih-Hurng Loh, Ming-Fang Cheng, Dar-Shih Hsieh, Chien-Yu Bai. Increasing Expression of Extracellular Matrix Metalloprotease Inducer in Ovary Tumors: Tissue Microarray Analysis of Immunostaining Score With Clinicopathological Parameters. International Journal of Gynecological Pathology 2006; 25(2): 140 doi: 10.1097/01.pgp.0000189244.57145.84
|
10 |
M. S. Bergholt, W. Zheng, K. Lin, K. Y. Ho, M. Teh, K. G. Yeoh, J. B. Y. So, Z. Huang. In Vivo Diagnosis of Esophageal Cancer Using Image-Guided Raman Endoscopy and Biomolecular Modeling. Technology in Cancer Research & Treatment 2011; 10(2): 103 doi: 10.7785/tcrt.2012.500185
|
11 |
Barbara Mroczko, Mirosław Kozłowski, Magdalena Groblewska, Marta Łukaszewicz, Jacek Nikliński, Wojciech Jelski, Jerzy Laudański, Lech Chyczewski, Maciej Szmitkowski. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients. Clinica Chimica Acta 2008; 389(1-2): 61 doi: 10.1016/j.cca.2007.11.023
|
12 |
Hu-Shan Cui, Yong-Min Kim, Sung-Jin Lee, Joong-Kook Choi, Dong-Soo Kim, Eui-Sung Choi, Hyun-Chul Shon, Kyoung-Jin Park, Hak-Kyo Lee. Synergistic Effect of Isoflavones on the BMP-4 Mediated Osteoblastic Differentiation of C2C12 Myoblast. The Journal of the Korean Orthopaedic Association 2007; 42(4): 537 doi: 10.4055/jkoa.2007.42.4.537
|
13 |
C. L. Lu, Y. Ji, D. Ge, J. Guo, J. Y. Ding. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer. Diseases of the Esophagus 2011; 24(4): 283 doi: 10.1111/j.1442-2050.2010.01135.x
|
14 |
Wen‐Lun Wang, Wei‐Lun Chang, Yi‐Chun Yeh, Ching‐Tai Lee, Chi‐Yang Chang, Jaw‐Town Lin, Bor‐Shyang Sheu. Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero‐digestive tract. Molecular Carcinogenesis 2013; 52(6): 438 doi: 10.1002/mc.21874
|
15 |
Li Shang, Mingrong Wang. Molecular alterations and clinical relevance in esophageal squamous cell carcinoma. Frontiers of Medicine 2013; 7(4): 401 doi: 10.1007/s11684-013-0286-y
|
16 |
Ying-Hui Zhu, Li Fu, Leilei Chen, Yan-Ru Qin, Haibo Liu, Fajun Xie, Tingting Zeng, Sui-Sui Dong, Jiangchao Li, Yan Li, Yongdong Dai, Dan Xie, Xin-Yuan Guan. Downregulation of the Novel Tumor Suppressor DIRAS1 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma. Cancer Research 2013; 73(7): 2298 doi: 10.1158/0008-5472.CAN-12-2663
|
17 |
W‐C Tsai, Y‐C Chao, W‐H Lee, A Chen, L‐F Sheu, J‐S Jin. Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue microarray analysis of immunohistochemical scores with clinicopathological parameters. Histopathology 2006; 49(4): 388 doi: 10.1111/j.1365-2559.2006.02516.x
|
18 |
Emma H. Allott, Joanne Lysaght, Mary Clare Cathcart, Claire L. Donohoe, Robert Cummins, Sarah A. McGarrigle, Elaine Kay, John V. Reynolds, Graham P. Pidgeon. MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation. Molecular Carcinogenesis 2013; 52(2): 144 doi: 10.1002/mc.21840
|
19 |
Hidayat Hussain, Ivan R. Green. A patent review of the therapeutic potential of isoflavones (2012-2016). Expert Opinion on Therapeutic Patents 2017; 27(10): 1135 doi: 10.1080/13543776.2017.1339791
|
20 |
JONG‐SHIAW JIN, DAR‐SHIH HSIEH, YEH‐FENG LIN, JIA‐YI WANG, LAI‐FA SHEU, WEI‐HWA LEE. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: Tissue microarray analysis of immunostaining score with clinicopathological parameters. International Journal of Urology 2006; 13(5): 573 doi: 10.1111/j.1442-2042.2006.01353.x
|
21 |
Wen-Chiuan Tsai, Ying Chen, Li-Chun Huang, Herng-Sheng Lee, Hsin-I Ma, Shih-Ming Huang, Huey-Kang Sytwu, Dueng-Yuan Hueng. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas. Journal of Neuro-Oncology 2013; 114(3): 281 doi: 10.1007/s11060-013-1184-5
|
22 |
Barbara Mroczko, Mirosław Kozłowski, Magdalena Groblewska, Marta Lukaszewicz, Jacek Nikliński, Jerzy Laudański, Lech Chyczewski, Maciej Szmitkowski. Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.. Folia Histochemica et Cytobiologica 2009; 46(4) doi: 10.2478/v10042-008-0065-9
|
23 |
Julian Crasta, Gayatri Ravikumar, Sharon Koorse, Premalatha Siddharta, Elizabeth Vallikad. Expression of adhesion molecule epithelial cadherin and matrix metalloproteinase-9 in squamous neoplasia of the uterine cervix. Southern African Journal of Gynaecological Oncology 2016; 8(1): 4 doi: 10.1080/20742835.2015.1110419
|
24 |
Feng Shi, Li Shang, Bei-Qing Pan, Xiao-Min Wang, Yan-Yi Jiang, Jia-Jie Hao, Yu Zhang, Yan Cai, Xin Xu, Qi-Min Zhan, Ming-Rong Wang. Calreticulin Promotes Migration and Invasion of Esophageal Cancer Cells by Upregulating Neuropilin-1 Expression via STAT5A. Clinical Cancer Research 2014; 20(23): 6153 doi: 10.1158/1078-0432.CCR-14-0583
|
25 |
Hong-Xu Liu, Yu Li, Xue-Dong Jiang, Hong-Nian Yin, Lin Zhang, Yu Wang, Jun Yang. Mutation screening of mismatch repair gene Mlh3 in familial esophageal cancer. World Journal of Gastroenterology 2006; 12(33): 5281-5286 doi: 10.3748/wjg.v12.i33.5281
|